Durvalumab after chemoradiation in lung cancer: how treatment duration affects survival and resource use

SSRN Electronic Journal 2026 Preprint Open access

Read full text
Authors: Anna Homeniuk, Anas Atrash
DOI: 10.2139/ssrn.6295955
Cited by: 0

Fields of Study & Subjects

Lung Cancer Diagnosis and Treatment Cancer Immunotherapy and Biomarkers Lung Cancer Research Studies

Publication details

Journal / source
SSRN Electronic Journal
Publication date
1 January 2026
Language
EN
Document type
Preprint